Profilaxia da pré-eclâmpsia no pré-natal

A maioria das mortes por pré-eclâmpsia e eclâmpsia é evitável através de cuidado efetivo às mulheres com essas complicações.

Download da apresentação em: <https://www.arca.fiocruz.br/handle/icict/29736>

Referências Citadas

1. Pregnancy hypertension
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse D, Spong CY. Pregnancy hypertension. In: Cunningham FG, ed. Williams Obstetrics, 23rd edn. McGraw-Hill Professional;2009:706

2. The FIGO Textbook of Pregnancy Hypertension: An evidence-based guide to monitoring, prevention and management
Edited by: Laura A. Magee MD, FRCPC, FACP Peter von Dadelszen MBChB, DPhil, FRANZCOG William Stones MD, FRCOG Matthews Mathai MD, PhD, FRCOG. ISBN: 978-0-9927545-5-6.

3. Recomendações da OMS para a Prevenção e tratamento da pré-eclâmpsia e da eclampsia
World Health Organization (WHO). Recommendations for Prevention and treatment of pre-eclampsia and eclampsia. Recomendações da OMS para a Prevenção e tratamento da pré-eclâmpsia e da eclampsia. 2011.

4. The World Health Organization Multicountry Survey on Maternal and Newborn Health project at a glance: the power of collaboration
Souza, J. and on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network (2014), The World Health Organization Multicountry Survey on Maternal and Newborn Health project at a glance: the power of collaboration. BJOG: Int J Obstet Gy, 121: v–viii. doi:10.1111/1471-0528.12690

5. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Hofmeyr GJ, Lawrie TA, Atallah ÁN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD001059. DOI: 10.1002/14651858.CD001059.pub4.

6. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
AU  – Rolnik, Daniel L.AU et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm PreeclampsiaPT  – Journal ArticleDP  – 2017TA  – New England Journal of MedicinePG  – 613-622VI  – 377IP  – 7AID  – 10.1056/NEJMoa1704559 [doi]PMID  – 286574174100  – http://www.nejm.org/doi/full/10.1056/NEJMoa1704559SO  – New England Journal of Medicine August 17, 2017 377(7):613

7. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study
Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study. J Perinatol. 2015 May;35(5):328-31. doi: 10.1038/jp.2014.214. Epub 2014 Dec 4. PubMed PMID: 25474553; PubMed Central PMCID: PMC4838902.

Como citar

FUNDAÇÃO OSWALDO CRUZ. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente. Postagens: Profilaxia da pré-eclâmpsia no pré-natal. Rio de Janeiro, 2018. Disponível em: <https://portaldeboaspraticas.iff.fiocruz.br/atencao-mulher/profilaxia-da-pre-eclampsia-no-pre-natal/>.